Weed, Inc. (BUDZ): EPS (Diluted)
-$0.01
Year ended 2025-12-31
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$0.01 | n/m | 2026-04-08, From 2025-01-01 |
| 2024-12-31 | $0.00 | n/m | 2026-04-08, From 2024-01-01 |
| 2023-12-31 | $0.00 | n/a | 2025-03-31, From 2023-01-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Weed, Inc. (BUDZ) | 2025-12-31 | -$0.01 | n/m |
| NRC Health (NRC) | 2025-12-31 | $50.00 | n/m |
| Incyte Corp (INCY) | 2025-12-31 | $6.41 | n/m |
| Icon PLC (ICLR) | 2025-12-31 | $2.90 | -67.4% |
| Charles River Laboratories International, Inc. (CRL) | 2025-12-27 | -$2.91 | n/m |
| MaxCyte, Inc. (MXCT) | 2025-12-31 | -$0.42 | n/m |
| Cannabis Bioscience International Holdings, Inc. (CBIH) | 2025-05-31 | $0.00 | n/m |
| Iqvia Holdings Inc. (IQV) | 2025-12-31 | $7.84 | +4.7% |
| iSpecimen Inc. (ISPC) | 2025-12-31 | -$2.28 | n/m |
Compare BUDZ, NRC, INCY, ICLR side by side · Screen every company in Services-Commercial Physical & Biological Research ↗